LTB4 receptor antagonists (CNRS)

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug NameLTB4 receptor antagonists (CNRS)
Drug Alias NameLTB4 antagonists (Montpellier University)PH-163
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionLeukotriene B4 receptor antagonists
TargetsLeukotriene B4 receptor
Therapy Area/IndicationsInflammation
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryFrance
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesUniversity of Montpellier
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesUniversity of Montpellier
Active IndicationsN/A
Inactive IndicationsInflammation

Other Information

ATC CodeN/A
Related LinksN/A